Helander, A; Böttcher, M; Fehr, C et al.
Detection times for urinary ethyl glucuronide and ethyl sulfate in heavy drinkers during alkohol detoxificationAlcohol Alcohol. Bd. 44. H. 1. 2009 S. 55-61
Eidens, M; Weise, A; Prause, S et al.
Development and validation of a high-throughput screening method for two polymorphisms in the serotonin transporter gene.Mol Diagn Ther. Bd. 13. H. 1. 2009 S. 25-9
Fellgiebel, A; Keller, I; Marin, D et al.
Diagnostic utility of different MRI and MR angiography measures in Fabry disease.Neurology. Bd. 72. H. 1. 2009 S. 63-8
Drueke, B; Baetz, J; Boecker, M et al.
Differential effects of escitalopram on attention: a placebo-controlled, double-blind cross-over studyPsychopharmacology (Berl). Bd. 207. H. 2. 2009 S. 213-23
Schanz, B; Stranz, S
DRG in der Psychiatrie und PsychosomatikDie Schwester Der Pfleger. Bd. 48. H. 12. 2009 S. 1229-1231
Waldschmitt, C; Vogel, F; Pfuhlmann, B et al.
Duloxetine serum concentrations and clinical effects. Data from a therapeutic drug monitoring (TDM) surveyPharmacopsychiatry. Bd. 42. H. 5. 2009 S. 189-193
Schroeder, A; Fahrenholz, F; Schmitt, U
Effect of a dominant-negative form of ADAM10 in a mouse model of Alzheimer's disease.J Alzheimers Dis. Bd. 16. H. 2. 2009 S. 309-14
Schulte-Herbrüggen, O; Fuchs, E; Ziegler, A et al.
Effects of escitalopram on the regulation of BDNF and NGF protein levels in a rat model of chronic stressJ Neurosci Res. Bd. 87. H. 11. 2009 S. 2551-2560
Jacob, GA; Hellstern, K; Ower, N et al.
Emotional reactions to standardized stimuli in women with borderline personality disorder: stronger negative affect, but no differences in reactivityJ Nerv Ment Dis. Bd. 197. H. 11. 2009 S. 808-15
Zernig, G; Hiemke, C; Havemann-Reinecke, U et al.
Empfehlungen für die gutachterliche Bewertung von Medikamentenspiegeln in der Psychiatrie im gerichtsanhängigen SchadensfallPsychopharmakotherapie. Bd. 16. H. 2. 2009 S. 57-65